Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Background: Dolutegravir, a component of the preferred first-line antiretroviral therapy (ART) regimen has been associated with increased weight gain, which is markedly higher when combined with tenofovir alafenamide (TAF), the newer tenofovir prodrug instead of tenofovir disoproxil fumarate (TDF)....
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Medicine
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|